Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
Background and AimsPrediction of pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer is critical for surgical planning and evaluation of NAC efficacy. The purpose of this project was to assess the efficiency of a novel nomogram based on ultrasound and clinicop...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d0ca8c3b1404f3485b108f708bb6cd8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9d0ca8c3b1404f3485b108f708bb6cd8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9d0ca8c3b1404f3485b108f708bb6cd82021-11-30T13:03:01ZPredicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram2234-943X10.3389/fonc.2021.718531https://doaj.org/article/9d0ca8c3b1404f3485b108f708bb6cd82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.718531/fullhttps://doaj.org/toc/2234-943XBackground and AimsPrediction of pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer is critical for surgical planning and evaluation of NAC efficacy. The purpose of this project was to assess the efficiency of a novel nomogram based on ultrasound and clinicopathological features for predicting pCR after NAC.MethodsThis retrospective study included 282 patients with advanced breast cancer treated with NAC from two centers. Patients received breast ultrasound before NAC and after two cycles of NAC; and the ultrasound, clinicopathological features and feature changes after two cycles of NAC were recorded. A multivariate logistic regression model was combined with bootstrapping screened for informative features associated with pCR. Then, we constructed two nomograms: an initial-baseline nomogram and a two-cycle response nomogram. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were analyzed. The C-index was used to evaluate predictive accuracy.ResultsSixty (60/282, 21.28%) patients achieved pCR. Triple-negative breast cancer (TNBC) and HER2-amplified types were more likely to obtain pCR. Size shrinkage, posterior acoustic pattern, and elasticity score were identified as independent factors by multivariate logistic regression. In the validation cohort, the two-cycle response nomogram showed better discrimination than the initial-baseline nomogram, with the C-index reaching 0.79. The sensitivity, specificity, and NPV of the two-cycle response nomogram were 0.77, 0.77, and 0.92, respectively.ConclusionThe two-cycle response nomogram exhibited satisfactory efficiency, which means that the nomogram was a reliable method to predict pCR after NAC. Size shrinkage after two cycles of NAC was an important in dependent factor in predicting pCR.Hao CuiDantong ZhaoPeng HanXudong ZhangWei FanXiaoxuan ZuoPanting WangNana HuHanqing KongFuhui PengYing WangJiawei TianLei ZhangFrontiers Media S.A.articlebreast cancerneoadjuvant chemotherapyultrasoundpathological complete responsenomogramNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
breast cancer neoadjuvant chemotherapy ultrasound pathological complete response nomogram Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
breast cancer neoadjuvant chemotherapy ultrasound pathological complete response nomogram Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Hao Cui Dantong Zhao Peng Han Xudong Zhang Wei Fan Xiaoxuan Zuo Panting Wang Nana Hu Hanqing Kong Fuhui Peng Ying Wang Jiawei Tian Lei Zhang Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram |
description |
Background and AimsPrediction of pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer is critical for surgical planning and evaluation of NAC efficacy. The purpose of this project was to assess the efficiency of a novel nomogram based on ultrasound and clinicopathological features for predicting pCR after NAC.MethodsThis retrospective study included 282 patients with advanced breast cancer treated with NAC from two centers. Patients received breast ultrasound before NAC and after two cycles of NAC; and the ultrasound, clinicopathological features and feature changes after two cycles of NAC were recorded. A multivariate logistic regression model was combined with bootstrapping screened for informative features associated with pCR. Then, we constructed two nomograms: an initial-baseline nomogram and a two-cycle response nomogram. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were analyzed. The C-index was used to evaluate predictive accuracy.ResultsSixty (60/282, 21.28%) patients achieved pCR. Triple-negative breast cancer (TNBC) and HER2-amplified types were more likely to obtain pCR. Size shrinkage, posterior acoustic pattern, and elasticity score were identified as independent factors by multivariate logistic regression. In the validation cohort, the two-cycle response nomogram showed better discrimination than the initial-baseline nomogram, with the C-index reaching 0.79. The sensitivity, specificity, and NPV of the two-cycle response nomogram were 0.77, 0.77, and 0.92, respectively.ConclusionThe two-cycle response nomogram exhibited satisfactory efficiency, which means that the nomogram was a reliable method to predict pCR after NAC. Size shrinkage after two cycles of NAC was an important in dependent factor in predicting pCR. |
format |
article |
author |
Hao Cui Dantong Zhao Peng Han Xudong Zhang Wei Fan Xiaoxuan Zuo Panting Wang Nana Hu Hanqing Kong Fuhui Peng Ying Wang Jiawei Tian Lei Zhang |
author_facet |
Hao Cui Dantong Zhao Peng Han Xudong Zhang Wei Fan Xiaoxuan Zuo Panting Wang Nana Hu Hanqing Kong Fuhui Peng Ying Wang Jiawei Tian Lei Zhang |
author_sort |
Hao Cui |
title |
Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram |
title_short |
Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram |
title_full |
Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram |
title_fullStr |
Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram |
title_full_unstemmed |
Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram |
title_sort |
predicting pathological complete response after neoadjuvant chemotherapy in advanced breast cancer by ultrasound and clinicopathological features using a nomogram |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/9d0ca8c3b1404f3485b108f708bb6cd8 |
work_keys_str_mv |
AT haocui predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT dantongzhao predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT penghan predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT xudongzhang predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT weifan predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT xiaoxuanzuo predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT pantingwang predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT nanahu predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT hanqingkong predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT fuhuipeng predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT yingwang predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT jiaweitian predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram AT leizhang predictingpathologicalcompleteresponseafterneoadjuvantchemotherapyinadvancedbreastcancerbyultrasoundandclinicopathologicalfeaturesusinganomogram |
_version_ |
1718406579430096896 |